EUVIMEDEUVIMED entdecken
Open Access

Tissue Microarray Immunohistochemical Staining for Androgen Receptor in Breast Cancer in a Ghanaian Cohort

Babatunde M Duduyemi, William G Ayibor, Francis Agyemang-Yeboah

Annals of African Medicine · 2024

DOI: 10.4103/aam.aam_83_23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of African Medicine, 2024. Verfasst von Babatunde M Duduyemi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. Hauptthemen laut MEDLINE: Receptors, Androgen, Immunohistochemistry, Triple Negative Breast Neoplasms, Tissue Array Analysis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite the advancement in therapy, breast cancer still remains the most common malignancy in women globally due in part to its heterogeneity. Triple-negative breast cancer (TNBC) represents up to 20% of all breast cancer variants, an aggressive disease with poorer outcomes compared to other breast cancer subtypes. No targeted therapies are currently approved for TNBC, and newer treatment approaches are seriously needed. Androgen receptor (AR), another hormonal receptor, is often expressed in breast cancer, and its role depends on the relative levels of circulating estrogens and androgens. This study aimed to assess the expression of AR in breast cancer in a tertiary hospital in Ghana. Methodology: Immunohistochemical staining for AR was performed on tissue microarray (TMA) blocks, of which estrogen receptor, progesterone receptor, and Her-2/neu had already been done. 197 cases were suitable for the study. Results from the immunostaining were analyzed using the SPSS version 23 for descriptive statistics and correlations (χ 2 and Pearson tests).

Results

197 TMA cases were used. TNBCs constitute 61.9% of the cancers. The majority of these tumors were grade III, ductal carcinoma NST. The mean age was 49.86 ± 14.09, and the modal age group was 40–49 years. Our cases showed 23% AR expression in triple-negative cancers. The study also established that AR is more frequently expressed in low-grade tumors compared to high-grade ones.

Conclusion

There is an appreciable level of AR expression in our cases; however, most are quadruple negative. However, AR is more frequently expressed in low-grade tumors than high-grade ones.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, AndrogenImmunohistochemistryTriple Negative Breast NeoplasmsTissue Array AnalysisBiomarkers, TumorHumansFemaleGhanaMiddle AgedAdultReceptors, ProgesteroneBreast NeoplasmsReceptors, EstrogenAgedCohort StudiesErb-b2 Receptor Tyrosine KinasesNeoplasm Grading

Substanzen

Receptors, AndrogenBiomarkers, TumorReceptors, ProgesteroneReceptors, EstrogenErb-b2 Receptor Tyrosine KinasesAR protein, human

Autor:innen und Institutionen

  • Department of Pathology, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Department of Pathology, University of Sierra Leone Teaching Hospitals Complex, Freetown, Sierra Leone.
  • Department of Molecular Medicine, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.

Zitieren

APA

Duduyemi, B. M., Ayibor, W. G., & Agyemang-Yeboah, F. (2024). Tissue Microarray Immunohistochemical Staining for Androgen Receptor in Breast Cancer in a Ghanaian Cohort. Annals of African Medicine. https://doi.org/10.4103/aam.aam_83_23

Vancouver

Duduyemi BM, Ayibor WG, Agyemang-Yeboah F. Tissue Microarray Immunohistochemical Staining for Androgen Receptor in Breast Cancer in a Ghanaian Cohort. Annals of African Medicine. 2024. doi:10.4103/aam.aam_83_23

BibTeX
@article{Duduyemi2024,
  author = {Duduyemi, Babatunde M and Ayibor, William G and Agyemang-Yeboah, Francis},
  title = {Tissue Microarray Immunohistochemical Staining for Androgen Receptor in Breast Cancer in a Ghanaian Cohort},
  journal = {Annals of African Medicine},
  year = {2024},
  doi = {10.4103/aam.aam_83_23}
}
Kostenlos starten →